Signaling pathways
-
BA8253 RilapladibSummary: Rilapladib (SB659032) is a selective inhibitor of lipoprotein-associated phospholipase A. - BA8254 GSK2647544Summary: GSK2647544 is an oral, selective inhibitor.
- BA8255 ASM-IN-1Summary: ASM-IN-1 is a potent orally active acid sphingomyelinase inhibitor.
- BA8256 ML-298Summary: ML298 is a potent and selective inhibitor.
- BA8257 LCL521Summary: LCL521 is an acidic ceramidase inhibitor.
- BA8258 Lp-PLA2-IN-3Summary: Lp-PLA2-IN-3 is a potent, orally available inhibitor of lipoprotein-associated phospholipase A2.
- BA8259 VU0364739Summary: VU0364739 is a selective inhibitor (22nM).
- BA8260 CAY10502Summary: CAY10502 is a potent calcium-dependent (cPLAα) inhibitor with 4.3 nM for the isolated enzyme.
- BA8261 VU533Summary: NAPE-PLDactivator (VU533) is a potent activator.
- BA8262 GiripladibSummary: Giripladib (PLA-695) is a cytoplasmic phospholipase A inhibitor of the indole class.